Status:

COMPLETED

Change of Retinally-Induced Aniseikonia in Patients With Epiretinal Membrane After Vitrectomy

Lead Sponsor:

Yonsei University

Conditions:

Epiretinal Membranectomy

Eligibility:

All Genders

20-90 years

Brief Summary

Epiretinal membrane is common disease, affecting 5\~10 % incidence over 60 years old population. It reduce visual acuity, cause metamorphopsia. In the past, vitrectomy and epiretinal membranectomy was...

Eligibility Criteria

Inclusion

  • Idiopathic epiretinal membrane who had impaired vision or metamorphopsia, want to undergo vitrectomy
  • Age more than 20 years and less than 90 years old

Exclusion

  • secondary epiretinal membrane due to retinal surgery,
  • impaired visual acuity less than 20/40 in the normal eye(Snellen chart) due to severe cataract
  • glaucoma patients
  • complication during vitrectomy (ex. Retinal tear, silicone oil injection, …)
  • other retinal disease except epiretinal membrane
  • other ocular surgery history within 3 months
  • intellectual problems or illiterate whom could not obtained informed consent

Key Trial Info

Start Date :

July 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT01901406

Start Date

July 1 2013

End Date

June 1 2014

Last Update

August 12 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Vision Research, Department of Ophthalmology, Gangnam Severance Hospital

Seoul, South Korea, 135-720